• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. ATLAS GOLD PTA BALLOON DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. ATLAS GOLD PTA BALLOON DILATATION CATHETER Back to Search Results
Catalog Number ATG80122
Device Problem Device Contamination with Chemical or Other Material (2944)
Patient Problem No Patient Involvement (2645)
Event Type  malfunction  
Manufacturer Narrative
No medical records and no medical images were provided to the manufacturer.The lot number for the device was provided.The device history records are currently under review.The return of the device is pending.The investigation is currently under way.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that during preparation for an angioplasty procedure the sterile packaging allegedly contained a particle inside.There was no reported patient contact.
 
Manufacturer Narrative
Manufacturing review: a manufacturing review was conducted and there was nothing found to indicate there was a manufacturing related cause for this event.The lot met all release criteria.Visual/microscopic inspection: as the sample was not returned for evaluation, a visual/microscopic inspection could not be performed.Functional/performance evaluation: as the sample was not returned for evaluation, a functional/performance evaluation could not be performed.Medical records review: medical records were not provided; therefore, a review could not be performed.Image/photo review: images/photos were not provided; therefore, a review could not be performed.Conclusion: the investigation is inconclusive, as the sample was not returned for evaluation.The definitive root cause could not be determined based upon the available information.Labeling review: the current ifu (instructions for use) states: warnings: contents supplied sterile using ethylene oxide (eo).Non-pyrogenic.Do not use if sterile barrier is opened or damaged.Single patient use only.Do not reuse, reprocess, or re-sterilize.Precautions: carefully inspect the catheter prior to use to verify that catheter has not been damaged during shipment and that its size, shape, and condition are suitable for the procedure for which it is to be used.Do not use if product damage is evident.The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
It was reported that during preparation for an angioplasty procedure the sterile packaging allegedly contained a particle inside.There was no reported patient contact.
 
Manufacturer Narrative
Manufacturing review: a manufacturing review was conducted and there was nothing found to indicate there was a manufacturing related cause for this event.The lot met all release criteria.This is the only complaint reported to date for this lot number and failure mode.Visual/microscopic inspection: the sample was returned sealed inside the original packaging.The outer cardboard pouch was returned as well as the inner sealed sleeve.No visual defects were noted to either packaging.The user had indicated with an arrow where the alleged foreign material was located.The inner packaging at the arrow was examined under microscopic magnification (25x) and although pen markings were noted, a small foreign material was noted.The material appeared to be a small fiber/particle of some kind.The device was sent to the manufacturing site for further evaluation.Manufacturing site evaluation: the sample was received in the original packaging.The open sleeve contains an unopened pouch containing the catheter.Written on the outside of the pouch states "filament".The label contains the part number and lot number.The customer complaint number is written on the outside of the sleeve.The instructions for use is not present.The balloon side of the hub is marked 18 atm rbp and the wire side of the hub is marked.035".Visually inspected returned sample with unaided eye at 12" to 18" distance under normal room lighting.The foreign material was not detectable.The photos provided with the complaint request were taken under magnification which is not the method of visual inspection listed in the component specification.The complaint could not be confirmed.Medical records review: medical records were not provided; therefore, a review could not be performed.Image/photo review: images/photos were not provided; therefore, a review could not be performed.Conclusion: the device was returned for evaluation.The inner packaging sleeve was examined under microscopic magnification and a small filament/particle was noted within the sealed device packaging.The unopened device was sent to the manufacturing site for further evaluation; however, the material was not able to be detected.Although the foreign material was not observed at the manufacturing site, the investigation is confirmed for foreign material.The definitive root cause for the foreign material could not be determined based upon the available information.Labeling review: the current ifu (instructions for use) states: warnings: contents supplied sterile using ethylene oxide (eo).Non-pyrogenic.Do not use if sterile barrier is opened or damaged.Single patient use only.Do not reuse, reprocess, or re-sterilize.Precautions: carefully inspect the catheter prior to use to verify that catheter has not been damaged during shipment and that its size, shape, and condition are suitable for the procedure for which it is to be used.Do not use if product damage is evident.
 
Event Description
It was reported that during preparation for an angioplasty procedure the sterile packaging allegedly contained a particle inside.There was no reported patient contact.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATLAS GOLD PTA BALLOON DILATATION CATHETER
Type of Device
PTA BALLOON DILATATION CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
FUTUREMATRIX INTERVENTIONAL
1605 enterprise street
athens TX 75751
Manufacturer Contact
judith ludwig
1625 w 3rd st.
tempe, AZ 85281
4803032689
MDR Report Key6312654
MDR Text Key66862060
Report Number2020394-2017-00046
Device Sequence Number1
Product Code DQY
UDI-Device Identifier00801741060670
UDI-Public(01)00801741060670(17)190228(10)93PA0136
Combination Product (y/n)N
Reporter Country CodeTN
PMA/PMN Number
K122984
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign
Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date 07/19/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/08/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator No Information
Device Expiration Date02/28/2019
Device Catalogue NumberATG80122
Device Lot Number93PA0136
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/05/2017
Is the Reporter a Health Professional? No
Date Manufacturer Received07/17/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/29/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-